Major Histocompatibility Complex Class I–Recognizing Receptors Are Disease Risk Genes in Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a heterogeneous syndrome of which a subset of patients develops vascular inflammation. The genetic determinants that confer risk for rheumatoid vasculitis are not known, but patients with vascular complications are known to have an expansion of CD4+CD28null T cells, a cell population potentially involved in endothelial damage. CD4+CD28null T cell clones isolated from RA patients with vasculitis were found to express killer cell immunoglobulin–like receptors (KIRs) with the stimulatory KIR2DS2 often present in the absence of opposing inhibitory receptors with related specificities. To test the hypothesis that the KIR2DS2 gene is involved in the development of vasculitis, association studies were performed. The KIR2DS2 gene was significantly enriched among patients with rheumatoid vasculitis compared with normal individuals (odds ratio 5.56, P = 0.001) and patients with RA but no vasculitis (odds ratio 7.96, P = 0.001). Also, the distribution of human histocompatibility leukocyte antigen (HLA)-C, the putative ligand for KIRs, was significantly different in patients with rheumatoid vasculitis in comparison with the control populations. These data suggest that HLA class I–recognizing receptors and HLA class I genes are genetic risk determinants that modulate the pattern of RA expression. Specifically, KIR2DS2 in conjunction with the appropriate HLA-C ligand may have a role in vascular damage by regulating CD4+CD28null T cells.

[1]  Eric O Long,et al.  Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. , 1998, Journal of immunology.

[2]  Eric O Long,et al.  Regulation of immune responses through inhibitory receptors. , 1999, Annual review of immunology.

[3]  O. Mandelboim,et al.  Self and viral peptides can initiate lysis by autologous natural killer cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Paul Wordsworth,et al.  HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. , 1992, American journal of human genetics.

[5]  Eric O Long,et al.  Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. , 1995, Immunity.

[6]  M. Llano,et al.  HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R S Chaganti,et al.  Genomic organization and allelic polymorphism of the human killer cell inhibitory receptor gene KIR103. , 1997, Tissue antigens.

[8]  P. Shah,et al.  Plaque disruption and thrombosis. Potential role of inflammation and infection. , 1999, Cardiology clinics.

[9]  W. Seaman,et al.  DAP12-mediated Signal Transduction in Natural Killer Cells , 1998, The Journal of Biological Chemistry.

[10]  R. Winchester,et al.  The germline and somatic genetic basis for rheumatoid arthritis. , 1999, Current directions in autoimmunity.

[11]  D. Schaid,et al.  Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. , 1997, Arthritis and rheumatism.

[12]  J. Coligan,et al.  Recognition of Human Histocompatibility Leukocyte Antigen (HLA)-E Complexed with HLA Class I Signal Sequence–derived Peptides by CD94/NKG2 Confers Protection from Natural Killer Cell–mediated Lysis , 1998, The Journal of experimental medicine.

[13]  Eric O Long,et al.  A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. , 1997, Journal of immunology.

[14]  Eric O Long,et al.  Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. , 1996, Journal of immunology.

[15]  C. Weyand,et al.  Functional properties of CD4+CD28− T cells in the aging immune system , 1998, Mechanisms of Ageing and Development.

[16]  C. Weyand,et al.  CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. , 1996, The Journal of clinical investigation.

[17]  B. Dupont,et al.  Nucleotide and amino acid sequence alignment for human killer cell inhibitory receptors (KIR), 1998. , 2008, Tissue antigens.

[18]  M. Colonna,et al.  Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. , 1995, Science.

[19]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[20]  O. Mandelboim,et al.  Enhancement of Class II-Restricted T cell Responses by Costimulatory NK Receptors for Class I MHC Proteins , 1996, Science.

[21]  T. Mcclanahan,et al.  Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. , 1995, Journal of immunology.

[22]  G. Ferrara,et al.  HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Gregersen,et al.  The genetics revolution and the assault on rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[24]  L. Moretta,et al.  Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells , 1995, The Journal of experimental medicine.

[25]  P Parham,et al.  Human diversity in killer cell inhibitory receptor genes. , 1997, Immunity.

[26]  J. Yen,et al.  Killer Cell Activating Receptors Function as Costimulatory Molecules on CD4+CD28null T Cells Clonally Expanded in Rheumatoid Arthritis1 , 2000, The Journal of Immunology.

[27]  Jun Wu,et al.  Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells , 1998, Nature.

[28]  Eric O Long,et al.  Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. , 1995, Immunity.

[29]  C. Weyand,et al.  Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. , 1992, The Journal of clinical investigation.

[30]  D. Hafler,et al.  Natural killer activating receptors trigger interferon gamma secretion from T cells and natural killer cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[31]  L. Lanier.  NK cell receptors. , 1998, Annual review of immunology.

[32]  R. Biassoni,et al.  The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions , 1996, The Journal of experimental medicine.

[33]  P. Shah.  Potential Role of Inflammation and Infection , 1999 .

[34]  J. Strominger,et al.  Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  G. Nepom.  Major histocompatibility complex-directed susceptibility to rheumatoid arthritis. , 1998, Advances in immunology.

[36]  G. Gyapay,et al.  New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Nallasivam Palanisamy,et al.  Genomic organization and allelic polymorphism of the human killer cell inhibitory receptor gene KIR 103 , 1997 .

[38]  J. Strominger,et al.  Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2‐A and the activating receptor CD94/NKG2‐C to HLA‐E , 1999, The EMBO journal.

[39]  L. Lanier,et al.  Follow the Leader: NK Cell Receptors for Classical and Nonclassical MHC Class I , 1998, Cell.

[40]  U. Wagner,et al.  The influence of sex on the phenotype of rheumatoid arthritis. , 1998, Arthritis and rheumatism.

[41]  R. Frye,et al.  Perturbation of the T-cell repertoire in patients with unstable angina. , 1999, Circulation.

[42]  U. Wagner,et al.  Functional subsets of CD4 T cells in rheumatoid synovitis. , 1998, Arthritis and rheumatism.

[43]  R. Frye,et al.  Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. , 2000, Circulation.

[44]  J. Strominger,et al.  Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Wang,et al.  Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up‐regulation of its ligands B7‐1 (CD80) and B7‐2 (CD86) on T cells , 1998, Clinical and experimental immunology.